Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9432 | 1156 | 29.4 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
109 | 3 | RECTAL CANCER//COLORECTAL CANCER//COLONOSCOPY | 71522 |
1176 | 2 | THYMIDYLATE SYNTHASE//THYMIDINE PHOSPHORYLASE//5 FLUOROURACIL | 9333 |
9432 | 1 | DIHYDROPYRIMIDINE DEHYDROGENASE//DPYD//5 FLUOROURACIL | 1156 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | authKW | 1891378 | 14% | 44% | 163 |
2 | DPYD | authKW | 803299 | 4% | 72% | 42 |
3 | 5 FLUOROURACIL | authKW | 474318 | 24% | 6% | 280 |
4 | ENILURACIL | authKW | 317823 | 2% | 63% | 19 |
5 | DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY | authKW | 297584 | 1% | 87% | 13 |
6 | DPD DEFICIENCY | authKW | 237718 | 1% | 100% | 9 |
7 | DPYD GENE | authKW | 237718 | 1% | 100% | 9 |
8 | DIHYDROURACIL | authKW | 228562 | 1% | 58% | 15 |
9 | DPYS | authKW | 211305 | 1% | 100% | 8 |
10 | BETA UREIDOPROPIONASE | authKW | 203173 | 1% | 77% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5335 | 36% | 0% | 414 |
2 | Pharmacology & Pharmacy | 2648 | 29% | 0% | 338 |
3 | Chemistry, Analytical | 1049 | 14% | 0% | 163 |
4 | Medical Laboratory Technology | 674 | 4% | 0% | 49 |
5 | Biochemical Research Methods | 592 | 8% | 0% | 97 |
6 | Medicine, Research & Experimental | 280 | 7% | 0% | 80 |
7 | Genetics & Heredity | 107 | 5% | 0% | 63 |
8 | Toxicology | 86 | 3% | 0% | 39 |
9 | Endocrinology & Metabolism | 85 | 5% | 0% | 53 |
10 | Chemistry, Medicinal | 21 | 2% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INO F | 99551 | 1% | 54% | 7 |
2 | ONCOPHARMACOL PHARMACOGENET | 79233 | 1% | 50% | 6 |
3 | EMMA CHILDRENS HOSP | 59649 | 5% | 4% | 54 |
4 | ANTICANC PAUL P IN | 52826 | 0% | 100% | 2 |
5 | TREANT HEALTHGRP | 52826 | 0% | 100% | 2 |
6 | ONCOPHARMACOL | 43839 | 1% | 10% | 17 |
7 | GENET METAB DIS | 36198 | 3% | 4% | 34 |
8 | PDMP | 35216 | 0% | 67% | 2 |
9 | ONCOPHARMACOL UNIT | 33980 | 1% | 12% | 11 |
10 | AGII ANARGIRI CANC HOSPBASIC MED SCI BIOL PA | 26413 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 12903 | 5% | 1% | 60 |
2 | JOURNAL OF INHERITED METABOLIC DISEASE | 5931 | 3% | 1% | 32 |
3 | CLINICAL COLORECTAL CANCER | 4525 | 1% | 2% | 9 |
4 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 4206 | 4% | 0% | 44 |
5 | PHARMACOGENOMICS | 3330 | 1% | 1% | 15 |
6 | THERAPEUTIC DRUG MONITORING | 2522 | 2% | 1% | 19 |
7 | CLINICAL CANCER RESEARCH | 2385 | 3% | 0% | 37 |
8 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 1609 | 1% | 0% | 17 |
9 | ONCOLOGY-NEW YORK | 1441 | 1% | 1% | 9 |
10 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1421 | 1% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIHYDROPYRIMIDINE DEHYDROGENASE | 1891378 | 14% | 44% | 163 | Search DIHYDROPYRIMIDINE+DEHYDROGENASE | Search DIHYDROPYRIMIDINE+DEHYDROGENASE |
2 | DPYD | 803299 | 4% | 72% | 42 | Search DPYD | Search DPYD |
3 | 5 FLUOROURACIL | 474318 | 24% | 6% | 280 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
4 | ENILURACIL | 317823 | 2% | 63% | 19 | Search ENILURACIL | Search ENILURACIL |
5 | DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY | 297584 | 1% | 87% | 13 | Search DIHYDROPYRIMIDINE+DEHYDROGENASE+DEFICIENCY | Search DIHYDROPYRIMIDINE+DEHYDROGENASE+DEFICIENCY |
6 | DPD DEFICIENCY | 237718 | 1% | 100% | 9 | Search DPD+DEFICIENCY | Search DPD+DEFICIENCY |
7 | DPYD GENE | 237718 | 1% | 100% | 9 | Search DPYD+GENE | Search DPYD+GENE |
8 | DIHYDROURACIL | 228562 | 1% | 58% | 15 | Search DIHYDROURACIL | Search DIHYDROURACIL |
9 | DPYS | 211305 | 1% | 100% | 8 | Search DPYS | Search DPYS |
10 | BETA UREIDOPROPIONASE | 203173 | 1% | 77% | 10 | Search BETA+UREIDOPROPIONASE | Search BETA+UREIDOPROPIONASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN STAVEREN, MC , GUCHELAAR, HJ , VAN KUILENBURG, ABP , GELDERBLOM, H , MARING, JG , (2013) EVALUATION OF PREDICTIVE TESTS FOR SCREENING FOR DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY.PHARMACOGENOMICS JOURNAL. VOL. 13. ISSUE 5. P. 389-395 | 67 | 100% | 22 |
2 | MEULENDIJKS, D , CATS, A , BEIJNEN, JH , SCHELLENS, JHM , (2016) IMPROVING SAFETY OF FLUOROPYRIMIDINE CHEMOTHERAPY BY INDIVIDUALIZING TREATMENT BASED ON DIHYDROPYRIMIDINE DEHYDROGENASE ACTIVITY - READY FOR CLINICAL PRACTICE?.CANCER TREATMENT REVIEWS. VOL. 50. ISSUE . P. 23 -34 | 76 | 88% | 0 |
3 | MERCIER, C , CICCOLINI, J , (2006) PROFILING DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY IN PATIENTS WITH CANCER UNDERGOING 5-FLUOROURACIL/CAPECITABINE THERAPY.CLINICAL COLORECTAL CANCER. VOL. 6. ISSUE 4. P. 288-296 | 96 | 79% | 26 |
4 | AMSTUTZ, U , FROEHLICH, TK , LARGIADER, CR , (2011) DIHYDROPYRIMIDINE DEHYDROGENASE GENE AS A MAJOR PREDICTOR OF SEVERE 5-FLUOROURACIL TOXICITY.PHARMACOGENOMICS. VOL. 12. ISSUE 9. P. 1321-1336 | 61 | 82% | 59 |
5 | VAN KUILENBURQ, ABP , MARING, JG , (2013) EVALUATION OF 5-FLUOROURACIL PHARMACOKINETIC MODELS AND THERAPEUTIC DRUG MONITORING IN CANCER PATIENTS.PHARMACOGENOMICS. VOL. 14. ISSUE 7. P. 799-811 | 63 | 77% | 15 |
6 | PLOYLEARMSAENG, SA , FUHR, U , JETTER, A , (2006) HOW MAY ANTICANCER CHEMOTHERAPY WITH FLUOROURACIL BE INDIVIDUALISED?.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 6. P. 567-592 | 80 | 74% | 27 |
7 | VAN KUILENBURG, ABP , MEIJER, J , TANCK, MWT , DOBRITZSCH, D , ZOETEKOUW, L , DEKKERS, LL , ROELOFSEN, J , MEINSMA, R , WYMENGA, M , KULIK, W , ET AL (2016) PHENOTYPIC AND CLINICAL IMPLICATIONS OF VARIANTS IN THE DIHYDROPYRIMIDINE DEHYDROGENASE GENE.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1862. ISSUE 4. P. 754 -762 | 53 | 88% | 0 |
8 | BREDA, M , BARATTE, S , (2010) A REVIEW OF ANALYTICAL METHODS FOR THE DETERMINATION OF 5-FLUOROURACIL IN BIOLOGICAL MATRICES.ANALYTICAL AND BIOANALYTICAL CHEMISTRY. VOL. 397. ISSUE 3. P. 1191 -1201 | 65 | 77% | 12 |
9 | CAUDLE, KE , THORN, CF , KLEIN, TE , SWEN, JJ , MCLEOD, HL , DIASIO, RB , SCHWAB, M , (2013) CLINICAL PHARMACOGENETICS IMPLEMENTATION CONSORTIUM GUIDELINES FOR DIHYDROPYRIMIDINE DEHYDROGENASE GENOTYPE AND FLUOROPYRIMIDINE DOSING.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 94. ISSUE 6. P. 640 -645 | 34 | 89% | 95 |
10 | CICCOLINI, J , GROSS, E , DAHAN, L , LACARELLE, B , MERCIER, C , (2010) ROUTINE DIHYDROPYRIMIDINE DEHYDROGENASE TESTING FOR ANTICIPATING 5-FLUOROURACIL-RELATED SEVERE TOXICITIES: HYPE OR HOPE?.CLINICAL COLORECTAL CANCER. VOL. 9. ISSUE 4. P. 224 -228 | 45 | 98% | 31 |
Classes with closest relation at Level 1 |